Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c

Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results

February 2, 2022 4:00 PM EST

- Conference Call and Webcast Today, February 2, 2022 at 4:30 p.m. ET

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal first quarter ended December 31, 2021. The company is hosting a conference call today, February 2, 2022, at 4:30 p.m. ET to discuss the results.

Conference Call and Webcast Details

Investors may access a live audio webcast on the Company's website at... More